As of October 29, 2026, Halozyme Therapeutics had a market cap of $14.96 billion, which increased by 0.88% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.
Data updated: Oct 29, 2026, 4:00 PM ET
Halozyme Therapeutics, Inc. (HALO)
🌍 United States📈 NASDAQ🏭 Health Care🏢 Biotechnology
Note: Each point on the chart represents the market capitalization at the end of the trading day. Source: Data compiled from
EDGAR filings,
Bloomberg
and Yahoo Finance.
📈 Halozyme Therapeutics Market Cap History by Year and Month
Halozyme Therapeutics Market Cap History by Year and Month
Year / Month
Market Cap
% Change
2026
$14.96B
▲ 89.03%
$14.96B
▲ 18.82%
$12.59B
▲ 3.71%
$12.14B
▲ 24.09%
$9.783B
▲ 5.45%
$9.277B
▲ 17.53%
$7.893B
▲ 5.06%
$7.513B
▼ 1.49%
$7.627B
▼ 7.06%
$8.206B
▼ 2.69%
$8.433B
▲ 6.56%
2025
$7.914B
▲ 34.43%
$7.914B
▼ 5.75%
$8.397B
▲ 9.54%
$7.666B
▼ 11.06%
$8.619B
▲ 0.74%
$8.556B
▲ 21.97%
$7.015B
▲ 14.64%
$6.119B
▼ 11.43%
$6.909B
▼ 8.71%
$7.568B
▼ 3.70%
$7.859B
▲ 7.89%
$7.284B
▲ 4.43%
$6.975B
▲ 18.48%
2024
$5.887B
▲ 20.59%
$5.887B
▼ 4.00%
$6.132B
▼ 4.69%
$6.434B
▼ 11.62%
$7.28B
▼ 10.00%
$8.089B
▲ 15.56%
$7B
▲ 5.04%
$6.664B
▲ 18.22%
$5.637B
▲ 16.25%
$4.849B
▼ 6.17%
$5.168B
▲ 2.17%
$5.058B
▲ 17.87%
$4.291B
▼ 12.11%
2023
$4.882B
▼ 36.54%
$4.882B
▼ 4.27%
$5.1B
▲ 13.99%
$4.474B
▼ 11.21%
$5.039B
▼ 10.26%
$5.615B
▼ 0.92%
$5.667B
▲ 19.15%
$4.756B
▲ 11.38%
$4.27B
▲ 0.92%
$4.231B
▼ 15.85%
$5.028B
▼ 22.60%
$6.496B
▼ 7.16%
$6.997B
▼ 9.05%
2022
$7.693B
▲ 39.14%
$7.693B
▼ 0.63%
$7.742B
▲ 19.77%
$6.464B
▲ 20.91%
$5.346B
▼ 5.76%
$5.673B
▼ 15.74%
$6.733B
▲ 11.14%
$6.058B
▼ 4.49%
$6.343B
▲ 15.29%
$5.502B
▲ 0.05%
$5.499B
▲ 12.59%
$4.884B
▲ 2.63%
$4.759B
▼ 13.93%
2021
$5.529B
▼ 4.13%
$5.529B
▲ 19.44%
$4.629B
▼ 13.64%
$5.36B
▼ 6.54%
$5.735B
▼ 4.03%
$5.976B
▲ 1.70%
$5.876B
▼ 8.98%
$6.456B
▲ 9.50%
$5.896B
▼ 17.68%
$7.162B
▲ 19.81%
$5.978B
▼ 2.34%
$6.121B
▼ 4.75%
$6.426B
▲ 11.43%
2020
$5.767B
▲ 137.91%
$5.767B
▲ 9.10%
$5.286B
▲ 39.66%
$3.785B
▲ 6.38%
$3.558B
▼ 10.45%
$3.973B
▲ 6.92%
$3.716B
▲ 1.42%
$3.664B
▲ 11.17%
$3.296B
▲ 7.47%
$3.067B
▲ 25.95%
$2.435B
▼ 9.98%
$2.705B
▲ 4.24%
$2.595B
▲ 7.05%
2019
$2.424B
▲ 14.50%
$2.424B
▼ 14.68%
$2.841B
▲ 26.60%
$2.244B
▼ 1.23%
$2.272B
▼ 6.00%
$2.417B
▼ 2.78%
$2.486B
▼ 0.56%
$2.5B
▲ 16.50%
$2.146B
▼ 8.56%
$2.347B
▲ 0.34%
$2.339B
▼ 6.51%
$2.502B
▲ 6.83%
$2.342B
▲ 10.63%
2018
$2.117B
▼ 26.60%
$2.117B
▼ 11.31%
$2.387B
▲ 6.33%
$2.245B
▼ 14.38%
$2.622B
▼ 1.32%
$2.657B
▲ 1.72%
$2.612B
▲ 7.53%
$2.429B
▼ 8.31%
$2.649B
▼ 2.75%
$2.724B
▼ 3.27%
$2.816B
▲ 0.11%
$2.813B
▲ 5.47%
$2.667B
▼ 7.52%
2017
$2.884B
▲ 125.49%
$2.884B
▲ 8.50%
$2.658B
▲ 5.35%
$2.523B
▲ 2.35%
$2.465B
▲ 33.53%
$1.846B
▲ 2.61%
$1.799B
▼ 1.10%
$1.819B
▲ 9.05%
$1.668B
▼ 7.85%
$1.81B
▲ 7.61%
$1.682B
▲ 1.08%
$1.664B
▲ 11.23%
$1.496B
▲ 16.97%
2016
$1.279B
▼ 42.41%
$1.279B
▼ 16.35%
$1.529B
▲ 36.88%
$1.117B
▼ 28.58%
$1.564B
▲ 23.34%
$1.268B
▼ 1.40%
$1.286B
▲ 15.13%
$1.117B
▼ 14.01%
$1.299B
▼ 4.63%
$1.362B
▲ 11.37%
$1.223B
▲ 16.59%
$1.049B
▼ 7.00%
$1.128B
▼ 49.21%
2015
$2.221B
▲ 83.10%
$2.221B
▼ 2.54%
$2.279B
▲ 13.95%
$2B
▲ 16.55%
$1.716B
▼ 23.08%
$2.231B
▼ 25.18%
$2.982B
▲ 3.36%
$2.885B
▲ 30.66%
$2.208B
▲ 16.76%
$1.891B
▲ 4.13%
$1.816B
▼ 4.87%
$1.909B
▲ 6.35%
$1.795B
▲ 47.98%
2014
$1.213B
▼ 29.35%
$1.213B
▲ 10.17%
$1.101B
▼ 8.86%
$1.208B
▲ 5.69%
$1.143B
▼ 3.95%
$1.19B
▼ 2.46%
$1.22B
▼ 1.45%
$1.238B
▲ 25.81%
$0.984B
▲ 6.15%
$0.927B
▼ 41.40%
$1.582B
▼ 9.44%
$1.747B
▼ 2.62%
$1.794B
▲ 4.48%
2013
$1.717B
▲ 127.12%
$1.717B
▲ 2.02%
$1.683B
▲ 26.73%
$1.328B
▲ 5.56%
$1.258B
▲ 33.69%
$0.941B
▼ 2.39%
$0.964B
▲ 7.11%
$0.9B
▲ 12.64%
$0.799B
▲ 16.98%
$0.683B
▲ 4.59%
$0.653B
▲ 5.83%
$0.617B
▼ 18.17%
$0.754B
▼ 0.26%
2012
$0.756B
▼ 23.33%
$0.756B
▲ 7.69%
$0.702B
▲ 17.79%
$0.596B
▼ 29.88%
$0.85B
▲ 29.97%
$0.654B
▼ 35.63%
$1.016B
▲ 2.01%
$0.996B
▲ 15.95%
$0.859B
▼ 5.50%
$0.909B
▼ 36.57%
$1.433B
▲ 19.72%
$1.197B
▲ 9.02%
$1.098B
▲ 11.36%
2011
$0.986B
▲ 23.71%
$0.986B
▲ 0.31%
$0.983B
▲ 12.47%
$0.874B
▲ 37.42%
$0.636B
▼ 9.79%
$0.705B
▼ 1.95%
$0.719B
▲ 0.42%
$0.716B
▲ 3.32%
$0.693B
▲ 2.51%
$0.676B
▼ 1.31%
$0.685B
▼ 1.44%
$0.695B
▲ 3.58%
$0.671B
▼ 15.81%
2010
$0.797B
▲ 48.14%
$0.797B
▲ 14.35%
$0.697B
▼ 5.30%
$0.736B
▼ 4.91%
$0.774B
▲ 10.10%
$0.703B
▲ 6.52%
$0.66B
▲ 1.85%
$0.648B
▼ 3.86%
$0.674B
▼ 13.92%
$0.783B
▲ 6.68%
$0.734B
▲ 46.51%
$0.501B
▲ 0.80%
$0.497B
▼ 7.62%
2009
$0.538B
▲ 17.98%
$0.538B
▲ 7.60%
$0.5B
▼ 9.42%
$0.552B
▼ 14.81%
$0.648B
▼ 2.99%
$0.668B
▲ 5.53%
$0.633B
▲ 1.12%
$0.626B
▲ 7.93%
$0.58B
▲ 10.69%
$0.524B
▲ 15.67%
$0.453B
▲ 23.43%
$0.367B
▼ 21.91%
$0.47B
▲ 3.07%
2008
$0.456B
▼ 17.69%
$0.456B
▲ 50.99%
$0.302B
▼ 22.37%
$0.389B
▼ 34.62%
$0.595B
▼ 5.10%
$0.627B
▼ 2.34%
$0.642B
▲ 48.96%
$0.431B
▲ 4.61%
$0.412B
▲ 4.83%
$0.393B
▼ 22.33%
$0.506B
▲ 18.22%
$0.428B
▼ 0.23%
$0.429B
▼ 22.56%
2007
$0.554B
▲ 6.74%
$0.554B
▼ 15.81%
$0.658B
▼ 7.71%
$0.713B
▲ 7.22%
$0.665B
▼ 1.34%
$0.674B
▲ 9.59%
$0.615B
▼ 7.38%
$0.664B
▼ 9.66%
$0.735B
▲ 0.68%
$0.73B
▲ 27.40%
$0.573B
▼ 2.72%
$0.589B
▲ 13.49%
$0.519B
— 0.00%
2006
$0.519B
▲ 469.76%
$0.519B
▲ 179.03%
$0.186B
▲ 2.20%
$0.182B
▲ 10.98%
$0.164B
▼ 2.38%
$0.168B
▲ 15.86%
$0.145B
▼ 13.69%
$0.168B
▲ 10.53%
$0.152B
▼ 16.02%
$0.181B
▼ 14.62%
$0.212B
▲ 17.13%
$0.181B
▲ 60.18%
$0.113B
▲ 24.05%
2005
$91.091M
▼ 15.66%
$91.091M
▲ 0.55%
$90.591M
▲ 1.12%
$89.59M
▼ 15.48%
$0.106B
▲ 6.08%
$99.92M
▲ 17.65%
$84.932M
▼ 7.61%
$91.926M
▼ 8.07%
$0.1B
▲ 14.47%
$87.36M
▲ 6.71%
$81.869M
▼ 0.96%
$82.665M
▼ 14.28%
$96.432M
▼ 10.71%
2004
$0.108B
▼ 36.84%
$0.108B
▲ 0.93%
$0.107B
▲ 2.88%
$0.104B
▲ 16.43%
$89.325M
▲ 11.89%
$79.83M
▼ 25.39%
$0.107B
▼ 15.08%
$0.126B
▼ 22.22%
$0.162B
▼ 7.43%
$0.175B
▲ 2.34%
$0.171B
— 0.00%
All market cap values reflect closing prices for the period shown.
📊 Halozyme Therapeutics Market Cap and Other Industry Peers
Below are selected companies from the Biotechnology sector / subsector:
